Dr. Sachdev (Dev) Sidhu’s research focuses on developing antibody therapeutics. His research has applications in cancer, infectious and chronic diseases and other disorders. Dr. Sidhu’s team continues to develop new technologies, including synthetic antibody libraries and new antibody formats that have been applied to create therapeutics for COVID-19 and treatment-resistant cancers.